GSK’s Imigran Recovery Is First Triptan Approved For Nonprescription UK Sale
• By Melina A. Vissat
GlaxoSmithKline expects to make nonprescription Imigran Recovery (sumatriptan 50 mg) available in the UK in mid-June following approval for pharmacy sale by the Medicines & Healthcare products Regulatory Agency
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
